#takotsubo
Latest news and interesting information about takotsubo.
Seven-year trial for broken heart syndrome
Seven-year clinical trial for broken heart syndrome (Takotsubo) begins. Brenda Young's story and new treatment hope.
...
→
EN ▾
Immunovant director sells $192,000 in sharesEnphase Energy SWOT analysis: tax credits headwindsSeven-year trial for broken heart syndromeDelek director sells $227,842 in stockMP Materials COO buys $962,540 in stockGottheimer buys and sells stocksCongressman Tim Moore buys AT&T, IHG, Rolls Royce stocksRepublic Services CAO Sells $77,876 in StockLiquidia stock transfer worth $317,894 reportedHerbalife COO Troy Hicks sells $619,555 in stockImmunovant director sells $192,000 in sharesEnphase Energy SWOT analysis: tax credits headwindsSeven-year trial for broken heart syndromeDelek director sells $227,842 in stockMP Materials COO buys $962,540 in stockGottheimer buys and sells stocksCongressman Tim Moore buys AT&T, IHG, Rolls Royce stocksRepublic Services CAO Sells $77,876 in StockLiquidia stock transfer worth $317,894 reportedHerbalife COO Troy Hicks sells $619,555 in stock